A major advance in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in many kinds of malignancies, causing uncontrolled body https://bookmarkdistrict.com/story21672371/nanobodies-revive-the-p53-protein-new-new-hope-for-malignant-management